Form 4 for SBFM Sunshine Biopharma Inc.
Accepted 2026-08-11 16:23:05 ET · period of report 2026-08-07 · accession 0001683168-26-006206 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 16:23 | 2026-08-07 | SBFM | NATAN DAVID | Dir | A - Grant | $0.00 | +58.3K | 68.3K | +583% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-07 | A | A | 58,300 | $0.00 | 68,300 | D | — | — | (F1) Represents a stock award to the reporting person. |